1Funk ML, Rosenberg DM, L ok ASF. World-wide epidemiology of HBeAgnegative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat,2002,9(1):52-61. 被引量：1
2Lin CL, Liao LY, Liu CJ, et al. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. J Gastroenterol,2002,37(4):283-287. 被引量：1
3Cho SW, Shin YJ. Kim YS, et al. Changs of precore nucleic acid sequence in chronic hepatitis B patients with and without interferon administration. Hepatol Res, 1999,15:136-144. 被引量：1
4Chu CM. Precore stop mutant in anti-HBe-positive phases of chronic hepatitis B virus infection. Am J Gastroenterol,2002,97(8):2138-2139. 被引量：1
5Chu CM,Yeh CT, Lee CS,et al. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B; clinical characteristics and correlation with the course of HBeAg to anti-HBe seroconversion. J Clin Microbiol,2002,40(1):16-21. 被引量：1
8Vasiliadis T, Patsiaoura K, Saveriadis A, et al. Long term lamivudine therapy in patients with precore mutant HBV related liver disease.J Hepatol, 2002,36 (Suppl 1):172. 被引量：1
9Suzuki F. Suzuki Y, Tsubata A, et al. Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy. J Hepatol, 2002,37(6):824-830. 被引量：1
10Tatulli I. Francavilla R. Rizzo GL, et al. Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B.J Hepatol,2001,35(6):805-810. 被引量：1
